Reza Gamagami, M.D.
NPI 1275517153 · Surgery Physician · New Lenox, IL
Enrolled with Medicare as Practitioner - General Surgery · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1275517153
- Entity type
- Individual
- Primary specialty
- Surgery PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- Yes
- License
- 036-103521 (IL)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,031 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 239 | $92 |
| New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More99204 | 166 | $173 |
| Biopsy of Esophagus, Stomach, And/Or Upper Small Bowel Using a Flexible Endoscope43239 | 98 | $104 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 93 | $127 |
| Colorectal Cancer Screening; Colonoscopy on Individual at High RiskG0105 | 49 | $188 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 9 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Sod Sulf/Pot Chloride/Mag Sulfbrand: Sutab | 57 | 55 |
| Peg3350/Sod Sulf,bicarb,cl/Kclbrand: Gavilyte-G | 54 | 53 |
| Lipase/Protease/Amylasebrand: Creon | 34 | 11 |
| Peg3350/Sod Sulf,bicarb,cl/Kclbrand: Peg-3350 and Electrolytes | 30 | 29 |
| Cholestyramine (with Sugar)brand: Cholestyramine | 30 | 16 |
| Famotidine | 28 | — |
| Pantoprazole Sodium |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$198,781 across 203 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-12-03
- Last updated
- 2024-01-18
- Certified
- 2024-01-18
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.